These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 31746391)
1. miR‑218 functions as a tumor suppressor gene in cervical cancer. Liu Z; Mao L; Wang L; Zhang H; Hu X Mol Med Rep; 2020 Jan; 21(1):209-219. PubMed ID: 31746391 [TBL] [Abstract][Full Text] [Related]
2. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line. Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640 [TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Martinez I; Gardiner AS; Board KF; Monzon FA; Edwards RP; Khan SA Oncogene; 2008 Apr; 27(18):2575-82. PubMed ID: 17998940 [TBL] [Abstract][Full Text] [Related]
4. N6-methyladenosine methylation on FSCN1 mediated by METTL14/IGF2BP3 contributes to human papillomavirus type 16-infected cervical squamous cell carcinoma. Tian Q; Huang J; Zhang Q; Zhao J Clin Exp Pharmacol Physiol; 2024 Jun; 51(6):e13864. PubMed ID: 38679464 [TBL] [Abstract][Full Text] [Related]
5. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers. Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553 [TBL] [Abstract][Full Text] [Related]
6. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3. Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046 [TBL] [Abstract][Full Text] [Related]
7. TLR9 expression in uterine cervical lesions of Uyghur women correlate with cervical cancer progression and selective silencing of human papillomavirus 16 E6 and E7 oncoproteins in vitro. Hao Y; Yuan JL; Abudula A; Hasimu A; Kadeer N; Guo X Asian Pac J Cancer Prev; 2014; 15(14):5867-72. PubMed ID: 25081715 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional gene silencing of HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and in vivo. Zhou J; Peng C; Li B; Wang F; Zhou C; Hong D; Ye F; Cheng X; Lü W; Xie X Gynecol Oncol; 2012 Feb; 124(2):296-302. PubMed ID: 22056554 [TBL] [Abstract][Full Text] [Related]
9. Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells. Jiang B; Xue M Genet Mol Res; 2015 Sep; 14(3):10473-81. PubMed ID: 26400278 [TBL] [Abstract][Full Text] [Related]
10. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35). McFarlane M; MacDonald AI; Stevenson A; Graham SV J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103 [TBL] [Abstract][Full Text] [Related]
11. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway. Li B; Guo X; Li N; Chen Q; Shen J; Huang X; Huang G; Wang F Cell Oncol (Dordr); 2020 Jun; 43(3):489-503. PubMed ID: 32301035 [TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus type 16 E7 oncoprotein-induced upregulation of lysine-specific demethylase 5A promotes cervical cancer progression by regulating the microRNA-424-5p/suppressor of zeste 12 pathway. Liu J; Zhao H; Zhang Q; Shi Z; Zhang Y; Zhao L; Ren Y; Ou R; Xu Y Exp Cell Res; 2020 Nov; 396(1):112277. PubMed ID: 32918895 [TBL] [Abstract][Full Text] [Related]
13. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo. Hu D; Zhou J; Wang F; Shi H; Li Y; Li B Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522 [TBL] [Abstract][Full Text] [Related]
14. MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20. Yao T; Lin Z Biochim Biophys Acta; 2012 Feb; 1822(2):248-60. PubMed ID: 22001440 [TBL] [Abstract][Full Text] [Related]
15. Down-regulation of HPGD by miR-146b-3p promotes cervical cancer cell proliferation, migration and anchorage-independent growth through activation of STAT3 and AKT pathways. Yao S; Xu J; Zhao K; Song P; Yan Q; Fan W; Li W; Lu C Cell Death Dis; 2018 Oct; 9(11):1055. PubMed ID: 30333561 [TBL] [Abstract][Full Text] [Related]
16. miR-106a Regulates Cell Proliferation and Autophagy by Targeting LKB1 in HPV-16-Associated Cervical Cancer. Cui X; Wang X; Zhou X; Jia J; Chen H; Zhao W Mol Cancer Res; 2020 Aug; 18(8):1129-1141. PubMed ID: 32345599 [TBL] [Abstract][Full Text] [Related]
18. The PEI-introduced CS shell/PMMA core nanoparticle for silencing the expression of E6/E7 oncogenes in human cervical cells. Saengkrit N; Sanitrum P; Woramongkolchai N; Saesoo S; Pimpha N; Chaleawlert-Umpon S; Tencomnao T; Puttipipatkhachorn S Carbohydr Polym; 2012 Oct; 90(3):1323-9. PubMed ID: 22939347 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of microRNA-146a is associated with high-risk human papillomavirus infection and epidermal growth factor receptor overexpression in penile squamous cell carcinoma. Peta E; Cappellesso R; Masi G; Sinigaglia A; Trevisan M; Grassi A; Di Camillo B; Vassarotto E; Fassina A; Palù G; Barzon L Hum Pathol; 2017 Mar; 61():33-40. PubMed ID: 27818285 [TBL] [Abstract][Full Text] [Related]
20. HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m Hu C; Liu T; Han C; Xuan Y; Jiang D; Sun Y; Zhang X; Zhang W; Xu Y; Liu Y; Pan J; Wang J; Fan J; Che Y; Huang Y; Zhang J; Ding J; Yang S; Yang K Int J Biol Sci; 2022; 18(2):507-521. PubMed ID: 35002506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]